Form 4 for CELU Celularity Inc
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-29 · accession 0000899243-22-037162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-29 | 2022-11-29 | CELU | Hariri Robert J | CEO, Dir | P - Purchase | $1.71 | +40.0K | 8.06M | +0.5% | +$68.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-11-29 | P | A | 40,000 | $1.71 | 8,064,996 | D | — | — | (F1) This price reported in Column 4 is a weighted-average price. The shares were purchased in multiple transactions at prices ranging from $1.655 to $1.7799, inclusive. The reporting person undertakes to provide to Celularity Inc., any security holder of Celularity Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |